P127 Rates of infection and bleeding are not increased in patients (Pts) with MDS treated with azacitidine (AZA) compared with best supportive care (BSC)

Elsevier, Leukemia Research, (33), p. S133

Journal article published in 2009 by V. Santini

, L. Silverman, J. Seymour, P. Fenaux, G. Mufti, E. Hellström-Lindberg, G. Sanz, C. Finelli, J. Backstom, D. McKenzie, C. Beach

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving allowed

Upload

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by